Navigation Links
Novavax CEO to Present at the World Vaccine Congress 2009, Lyon, France
Date:10/6/2009

ROCKVILLE, Md., Oct. 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and CEO of Novavax, will be making two presentations at the World Vaccine Congress 2009 conference on October 7th, 2009 at the Palais des Congres de Lyon, Lyon, France. The first presentation by Dr. Singhvi titled, 'Innovative Approaches to RSV vaccine development and VLP based vaccines' will be presented under the 'FUTURE DIRECTION OF VACCINE R&D' section. The second presentation, 'How to advance manufacturing using scalable solutions' will be presented under the 'CELL CULTURE BASED PRODUCTION -- THE NEXT FRONTIER?' session.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.

SOURCE Novavax, Inc.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Novavax Announces Board of Director Changes
2. NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate
3. NOVAVAX Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus
4. Novavax Reports Second Quarter 2009 Financial Results
5. Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
6. Novavax Announces Release Date of 2009 Second Quarter, Financial Results and Investor Conference Call
7. Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
8. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
9. Novavax Announces Repayment of $5 Million of Convertible Debt
10. Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
11. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... (PRWEB) September 21, 2017 , ... ... scientific and technical congress to review the latest knowledge on these products, which ... international speakers will discuss the impact of Biostimulants on Plant Nutrition, Abiotic Stresses, ...
(Date:9/21/2017)... ... September 21, 2017 , ... Today, BioPharma Institute, a leading ... addition of 5 new courses to its prospectus. These include the eagerly-awaited ... Part 11 on Electronic Records and Electronic Signatures (Part 11 of Title 21 ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... the election of Paul Hermes, Entrepreneur in Residence at Medtronic, Inc., to serve ... developed a proprietary, tissue-engineered scaffold for anterior cruciate ligament (ACL) reconstruction that is ...
(Date:9/20/2017)... ... September 20, 2017 , ... Diversity focused business accelerator, The Refinery ... pitch competition to uncover the top technology-driven, women-led startups in Boston, MA, New Haven/Hamden, ... each city’s entrepreneurial events going on that week – in Boston, it will be ...
Breaking Biology Technology:
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
Breaking Biology News(10 mins):